Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Bent Singlet Cyclobutylcarbene: Computed Geometry, Properties, and Product Selectivity of a Nonclassical Carbene.

Rosenberg MG, Brinker UH.

J Org Chem. 2019 Sep 20;84(18):11873-11884. doi: 10.1021/acs.joc.9b01732. Epub 2019 Sep 6.

PMID:
31438680
2.

MAIT cells are activated in acute Dengue virus infection and after in vitro Zika virus infection.

Paquin-Proulx D, Avelino-Silva VI, Santos BAN, Silveira Barsotti N, Siroma F, Fernandes Ramos J, Coracini Tonacio A, Song A, Maestri A, Barros Cerqueira N, Felix AC, Levi JE, Greenspun BC, de Mulder Rougvie M, Rosenberg MG, Nixon DF, Kallas EG.

PLoS Negl Trop Dis. 2018 Jan 22;12(1):e0006154. doi: 10.1371/journal.pntd.0006154. eCollection 2018 Jan.

3.

Antiretroviral therapy in HIV-infected adolescents: clinical and pharmacologic challenges.

Dobroszycki J, Lee P, Romo DL, Rosenberg MG, Wiznia A, Abadi J.

Expert Rev Clin Pharmacol. 2017 May;10(5):509-516. doi: 10.1080/17512433.2017.1301205. Epub 2017 Mar 14. Review.

PMID:
28288535
4.

Competitive 1,2-C Atom Shifts in the Strained Carbene Spiro[3.3]hept-1-ylidene Explained by Distinct Ring-Puckered Conformers.

Rosenberg MG, Schrievers T, Brinker UH.

J Org Chem. 2016 Dec 16;81(24):12388-12400. Epub 2016 Dec 8.

PMID:
27978720
5.

Intermolecular Reactions of a Foiled Carbene with Carbonyl Compounds: The Effects of Trishomocyclopropyl Stabilization.

Apeland IM, Rosenberg MG, Arion VB, Kählig H, Brinker UH.

J Org Chem. 2015 Dec 4;80(23):11877-87. doi: 10.1021/acs.joc.5b01988. Epub 2015 Oct 22.

PMID:
26447842
6.

Bromination and accompanying rearrangement of the polycyclic oxetane 2,4-oxytwistane.

Rosenberg MG, Billing P, Brecker L, Brinker UH.

J Org Chem. 2014 Sep 19;79(18):8786-99. doi: 10.1021/jo5016129. Epub 2014 Sep 3.

PMID:
25136739
7.

HIV-1 drug resistance prevalence, drug susceptibility and variant characterization in the Jacobi Medical Center paediatric cohort, Bronx, NY, USA.

de Mulder M, York VA, Wiznia AA, Michaud HA, Nixon DF, Holguin A, Rosenberg MG.

HIV Med. 2014 Mar;15(3):135-43. doi: 10.1111/hiv.12089. Epub 2013 Sep 25.

8.

T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaques.

Champiat S, Garrison KE, Raposo RA, Burwitz BJ, Reed J, Tandon R, York VA, Newman LP, Nimityongskul FA, Wilson NA, Almeida RR, Martin JN, Deeks SG, Rosenberg MG, Wiznia AA, Spotts GE, Pilcher CD, Hecht FM, Ostrowski MA, Sacha JB, Nixon DF.

J Virol. 2013 Jun;87(11):6073-80. doi: 10.1128/JVI.00579-12. Epub 2013 Mar 27.

9.

Impact of HIV-1 infection and pregnancy on maternal health: comparison between perinatally and behaviorally infected young women.

Munjal I, Dobroszycki J, Fakioglu E, Rosenberg MG, Wiznia AA, Katz M, Steiner A, Sansary J, Heo M, Abadi J.

Adolesc Health Med Ther. 2013 Feb 21;4:51-8. doi: 10.2147/AHMT.S39885. eCollection 2013.

10.

Age-related expansion of Tim-3 expressing T cells in vertically HIV-1 infected children.

Tandon R, Giret MT, Sengupta D, York VA, Wiznia AA, Rosenberg MG, Kallas EG, Ndhlovu LC, Nixon DF.

PLoS One. 2012;7(9):e45733. doi: 10.1371/journal.pone.0045733. Epub 2012 Sep 24.

11.

HIV in the tropics: staging in the resource-limited setting.

Varughese JK, Rosenberg MG, Kim K.

Curr Opin Infect Dis. 2012 Oct;25(5):477-83. doi: 10.1097/QCO.0b013e3283567b00. Review.

PMID:
22744319
12.

Association of differentiation state of CD4+ T cells and disease progression in HIV-1 perinatally infected children.

Sharp ER, Willberg CB, Kuebler PJ, Abadi J, Fennelly GJ, Dobroszycki J, Wiznia AA, Rosenberg MG, Nixon DF.

PLoS One. 2012;7(1):e29154. doi: 10.1371/journal.pone.0029154. Epub 2012 Jan 11.

13.

Intra- and intermolecular reaction selectivities of γ-substituted adamantanylidenes.

Knoll W, Kaneno D, Bobek MM, Brecker L, Rosenberg MG, Tomoda S, Brinker UH.

J Org Chem. 2012 Feb 3;77(3):1340-60. doi: 10.1021/jo202132c. Epub 2012 Jan 12.

PMID:
22168480
14.

Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity.

Eriksson EM, Milush JM, Ho EL, Batista MD, Holditch SJ, Keh CE, Norris PJ, Keating SM, Deeks SG, Hunt PW, Martin JN, Rosenberg MG, Hecht FM, Nixon DF.

Blood. 2012 Jan 19;119(3):745-55. doi: 10.1182/blood-2010-12-324848. Epub 2011 Dec 1.

15.

Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects.

Tandon R, SenGupta D, Ndhlovu LC, Vieira RG, Jones RB, York VA, Vieira VA, Sharp ER, Wiznia AA, Ostrowski MA, Rosenberg MG, Nixon DF.

J Virol. 2011 Nov;85(21):11526-31. doi: 10.1128/JVI.05418-11. Epub 2011 Aug 31.

16.

Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents.

Sharp ER, Willberg CB, Kuebler PJ, Abadi J, Fennelly GJ, Dobroszycki J, Wiznia AA, Rosenberg MG, Nixon DF.

PLoS One. 2011;6(7):e21135. doi: 10.1371/journal.pone.0021135. Epub 2011 Jul 19.

17.

Human endogenous retrovirus K106 (HERV-K106) was infectious after the emergence of anatomically modern humans.

Jha AR, Nixon DF, Rosenberg MG, Martin JN, Deeks SG, Hudson RR, Garrison KE, Pillai SK.

PLoS One. 2011;6(5):e20234. doi: 10.1371/journal.pone.0020234. Epub 2011 May 25.

18.

Pregnancy in women with perinatally acquired HIV-infection: outcomes and challenges.

Phillips UK, Rosenberg MG, Dobroszycki J, Katz M, Sansary J, Golatt MA, Wiznia AA, Abadi J.

AIDS Care. 2011 Sep;23(9):1076-82. doi: 10.1080/09540121.2011.554643. Epub 2011 May 23.

19.

Profile of darunavir in the treatment of HIV-infected pediatric and adolescent patients.

Dobroszycki J, Abadi J, Wiznia AA, Rosenberg MG.

Adolesc Health Med Ther. 2011 Sep 14;2:85-93. doi: 10.2147/AHMT.S11177. eCollection 2011. Review.

20.

Decay kinetics of HIV-1 specific T cell responses in vertically HIV-1 exposed seronegative infants.

Holditch SJ, Eriksson EM, Tarosso LF, Kuebler PJ, Kallas EG, Nielsen EK, Wiznia AA, Rosenberg MG, Nixon DF.

Front Immunol. 2012 Jan 11;2:94. doi: 10.3389/fimmu.2011.00094. eCollection 2011.

21.

Cross-sectional dating of novel haplotypes of HERV-K 113 and HERV-K 115 indicate these proviruses originated in Africa before Homo sapiens.

Jha AR, Pillai SK, York VA, Sharp ER, Storm EC, Wachter DJ, Martin JN, Deeks SG, Rosenberg MG, Nixon DF, Garrison KE.

Mol Biol Evol. 2009 Nov;26(11):2617-26. doi: 10.1093/molbev/msp180. Epub 2009 Aug 10.

22.

Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression.

Snyder-Cappione JE, Loo CP, Carvalho KI, Kuylenstierna C, Deeks SG, Hecht FM, Rosenberg MG, Sandberg JK, Kallas EG, Nixon DF.

AIDS. 2009 Sep 24;23(15):1965-70. doi: 10.1097/QAD.0b013e32832b5134.

PMID:
19590406
23.

Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection.

Ndhlovu LC, Chapman JM, Jha AR, Snyder-Cappione JE, Pagán M, Leal FE, Boland BS, Norris PJ, Rosenberg MG, Nixon DF.

AIDS. 2008 May 11;22(8):990-2. doi: 10.1097/QAD.0b013e3282ff884e.

24.

Single-cell, phosphoepitope-specific analysis demonstrates cell type- and pathway-specific dysregulation of Jak/STAT and MAPK signaling associated with in vivo human immunodeficiency virus type 1 infection.

Lee AW, Sharp ER, O'Mahony A, Rosenberg MG, Israelski DM, Nolan GP, Nixon DF.

J Virol. 2008 Apr;82(7):3702-12. doi: 10.1128/JVI.01582-07. Epub 2008 Jan 23.

25.

Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.

Ballan WM, Vu BA, Long BR, Loo CP, Michaëlsson J, Barbour JD, Lanier LL, Wiznia AA, Abadi J, Fennelly GJ, Rosenberg MG, Nixon DF.

J Immunol. 2007 Sep 1;179(5):3362-70.

26.

Rational peptide selection to detect human immunodeficiency virus type 1-specific T-cell responses under resource-limited conditions.

Willberg CB, Pillai SK, Sharp ER, Rosenberg MG, Agudelo JD, Barbour JD, Nixon DF.

Clin Vaccine Immunol. 2007 Jun;14(6):785-8. Epub 2007 Apr 4.

27.

Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal.

Legrand FA, Nixon DF, Loo CP, Ono E, Chapman JM, Miyamoto M, Diaz RS, Santos AM, Succi RC, Abadi J, Rosenberg MG, de Moraes-Pinto MI, Kallas EG.

PLoS One. 2006 Dec 20;1:e102.

28.

Partial treatment interruption of protease inhibitor-based highly active antiretroviral therapy regimens in HIV-infected children.

Abadi J, Sprecher E, Rosenberg MG, Dobroszycki J, Sansary J, Fennelly G, Wiznia A.

J Acquir Immune Defic Syndr. 2006 Mar;41(3):298-303.

PMID:
16540930
29.

CD8 T cell effector maturation in HIV-1-infected children.

Jordan KA, Furlan SN, Gonzalez VD, Karlsson AC, Quigley MF, Deeks SG, Rosenberg MG, Nixon DF, Sandberg JK.

Virology. 2006 Mar 30;347(1):117-26. Epub 2006 Jan 6.

30.

Higher frequency of HIV-1-specific T cell immune responses in African American children vertically infected with HIV-1.

Sharp ER, Barbour JD, Karlsson RK, Jordan KA, Sandberg JK, Wiznia A, Rosenberg MG, Nixon DF.

J Infect Dis. 2005 Nov 15;192(10):1772-80. Epub 2005 Oct 5.

PMID:
16235176
31.

Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients.

Legrand FA, Abadi J, Jordan KA, Davenport MP, Deeks SG, Fennelly GJ, Wiznia AA, Nixon DF, Rosenberg MG.

AIDS. 2005 Oct 14;19(15):1575-85.

PMID:
16184026
32.

Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment.

Aandahl EM, Quigley MF, Moretto WJ, Moll M, Gonzalez VD, Sönnerborg A, Lindbäck S, Hecht FM, Deeks SG, Rosenberg MG, Nixon DF, Sandberg JK.

Blood. 2004 Dec 1;104(12):3672-8. Epub 2004 Aug 12.

PMID:
15308569
33.

Limited magnitude and breadth in the HLA-A2-restricted CD8 T-Cell response to Nef in children with vertically acquired HIV-1 infection.

Chandwani R, Jordan KA, Shacklett BL, Papasavvas E, Montaner LJ, Rosenberg MG, Nixon DF, Sandberg JK.

Scand J Immunol. 2004 Jan;59(1):109-14.

34.
35.

Inter- and innermolecular reactions of chloro(phenyl)carbene.

Rosenberg MG, Brinker UH.

J Org Chem. 2003 Jun 13;68(12):4819-32.

PMID:
12790587
36.

HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment.

Sandberg JK, Fast NM, Jordan KA, Furlan SN, Barbour JD, Fennelly G, Dobroszycki J, Spiegel HM, Wiznia A, Rosenberg MG, Nixon DF.

J Immunol. 2003 Apr 15;170(8):4403-10.

37.

Generation of CD3+CD8low thymocytes in the HIV type 1-infected thymus.

Keir ME, Rosenberg MG, Sandberg JK, Jordan KA, Wiznia A, Nixon DF, Stoddart CA, McCune JM.

J Immunol. 2002 Sep 1;169(5):2788-96.

38.

Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection.

Sandberg JK, Fast NM, Palacios EH, Fennelly G, Dobroszycki J, Palumbo P, Wiznia A, Grant RM, Bhardwaj N, Rosenberg MG, Nixon DF.

J Virol. 2002 Aug;76(15):7528-34.

39.

Insights into regioselective oxy (-O-) and imino (-NH-) group insertions of 3-nortricyclanone.

Rosenberg MG, Haslinger U, Brinker UH.

J Org Chem. 2002 Jan 25;67(2):450-6.

PMID:
11798317
40.

Effect of supramolecular inclusion on the selectivity of 3-nortricyclanylidene.

Rosenberg MG, Brinker UH.

J Org Chem. 2001 Feb 23;66(4):1517-22. No abstract available.

PMID:
11312994
41.

Clindamycin.

Rosenberg MG.

Pediatr Rev. 1996 Oct;17(10):373-4. No abstract available.

PMID:
8885648
42.

Antibiotic drug levels.

Rosenberg MG.

Pediatr Rev. 1995 Oct;16(10):397-8. No abstract available.

PMID:
7479436
43.

Expression of IgA and IgM Fc receptors on murine T lymphocytes.

Sandor M, Ibraghimov A, Rosenberg MG, Teeraratkul P, Lynch RG.

Immunol Res. 1992;11(3-4):169-80. Review.

PMID:
1287113

Supplemental Content

Loading ...
Support Center